About Mediflorence Medicaments Limited
Data last updated: 26 February 2026
Mediflorence Medicaments Limited is a public limited company based in New Delhi, Delhi, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 09 February 2012, the company has been in operation for over 14 years.
Registered with ROC Delhi under CIN U24100DL2012PLC231292.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sunil Kumar Sharma and Vibhu Sharma.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: B – 86 R Block Dilshad Garden, New Delhi, Delhi, India – 110095.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.62 Cr, a growth of 6% compared to the previous year.
The company is associated with 1 brand - Mediflorence. As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mediflorence.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressB – 86 R Block Dilshad Garden, New Delhi, Delhi, India – 110095
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Mediflorence Medicaments Limited
Mediflorence Medicaments Limited operates one associated brand: Mediflorence. These brands represent Mediflorence Medicaments Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, marketing, and distribution of medicines in India. | mediflorence.com |
Business Activity of Mediflorence Medicaments Limited
Mediflorence Medicaments Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Mediflorence Medicaments Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Mediflorence Medicaments Limited
Mediflorence Medicaments Limited is audited by HARISH CHANDRA & ASSOCIATES for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HARISH CHANDRA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Mediflorence Medicaments Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mediflorence Medicaments Limited
Mediflorence Medicaments Limited is currently managed by 4 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Sharma | Director | 09 Feb 2012 | 14 Years 6 Months | Current |
| Vibhu Sharma | Director | 15 Mar 2021 | 5 Years 5 Months | Current |
| Nishant Agrawal | Director | 30 Sep 2013 | 12 Years 10 Months | Current |
|
Bijender Kumar Jain
Also directs:
Integra Life Sciences Private Limited
|
Director | 09 Feb 2012 | 14 Years 6 Months | Current |
Financials of Mediflorence Medicaments Limited FY 2025 filings available
Mediflorence Medicaments Limited reported revenue of ₹5.62 Cr (up 6.00% YoY) for FY 2025.
Ten-year financial statements for Mediflorence Medicaments Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Mediflorence Medicaments Limited
Shareholding and ownership data for Mediflorence Medicaments Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mediflorence Medicaments Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Nov 2017 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Mediflorence Medicaments Limited
View historical data on people associated with Mediflorence Medicaments Limited, including employment history and EPFO contributions.
Employee and EPFO history for Mediflorence Medicaments Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Mediflorence Medicaments Limited
GST registrations and filing compliance for Mediflorence Medicaments Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Mediflorence Medicaments Limited
Credit ratings, litigation, and regulatory alerts for Mediflorence Medicaments Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mediflorence Medicaments Limited
MSME payment history for Mediflorence Medicaments Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mediflorence Medicaments Limited
Corporate group structure for Mediflorence Medicaments Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mediflorence Medicaments Limited
MCA filings and documents for Mediflorence Medicaments Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Mediflorence Medicaments Limited
Frequently Asked Questions about Mediflorence Medicaments Limited
Mediflorence Medicaments Limited is an active public limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 09 February 2012 (14+ years old) and is registered under CIN U24100DL2012PLC231292.
Mediflorence Medicaments Limited reported revenue of ₹5.62 Cr for FY 2025 (up 6.00% YoY).
The current directors of Mediflorence Medicaments Limited are:
- Sunil Kumar Sharma - Director
- Vibhu Sharma - Director
- Nishant Agrawal - Director
- Bijender Kumar Jain - Director
The primary industry of Mediflorence Medicaments Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Mediflorence Medicaments Limited can be reached at the registered office: B – 86 R Block Dilshad Garden, New Delhi, Delhi, India – 110095, or through the website mediflorence.com.
The authorised capital is ₹10 Lakh, and the paid-up capital is ₹10 Lakh.